MSH|^~\&|LAB|SMH|||202003041026||ORU^R01|4180096|D|2.3|||AL|NE
PID|1||SM00044281|RC6243|LABTEST^ACADEMIC^||20180321|M||||||||||SM005226/18|9876209312
OBR|1|40096^LAB|00030240^0403:H00002R^LAB^040320:H2^40096|210.0000^MALARIA^Malaria Profile^^^XXX-1339||202003041025|202003041025|||||||202003041025||||||||||LAB|I||||
OBR|2|40096^LAB|00030240^0403:H00002R^LAB^040320:H2^40096|210.0550^MALNAT^Malaria NAT^^^||202003041025|202003041025|||||||202003041025||||||||||LAB|F||||
OBX|1|ST|210.0560^MALNAT R^Malaria NAT^^^|1|Positive^^N||Negative|H||A^S|F|||202003041026
NTE|1||Further testing to follow.  This assay does not distinguish
NTE|2||between residual nucleic acid (which may persist after
NTE|3||adequate treatment), and viable intact parasites. This assay
NTE|4||may detect low-grade asymptomatic parasitemia from
NTE|5||individuals exposed to malaria-endemic areas.